Bottom line
Is WMNAX a good fund? The bottom line
WMNAX is a share class of Westwood Alternative Income Fund, a managed alternatives mutual fund from Fidelity.
Annual fees run 1.01% — about $101 a year on every $10,000 invested, cheaper than 77% of alternatives funds we track.
It returned +7.6% over one year, +4.3% a year over five years (as of Dec 31, 2025, per its prospectus).
With $181 million in net assets and 134 holdings, its largest position is First American Funds Inc (6.5%) and the top 10 make up 26.6% of the portfolio.
This share class carries a front-end sales charge of up to 3%; a no-load class or ETF alternative can avoid it.
What stands out
- Low cost: cheaper than 77% of alternatives peers
What to watch
- Front-end sales load up to 3%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What WMNAX invests in
The investment objective of the Westwood Alternative Income Fund (the Fund or Alternative Income Fund) seeks to provide absolute returns through a combination of current income and capital appreciation with low correlation to equity and fixed income markets.
The Fund employs an absolute return strategy, which means that the Fund seeks to earn a positive total return through a combination of current income and capital appreciation in all market conditions, by maintaining a portfolio that is designed to have low volatility and low correlations with equity and fixed income markets over a full market cycle. In seeking to achieve its goals, the Fund invests primarily in income producing convertible securities. Convertible securities include, but are not limited to, corporate bonds, debentures, notes or preferred stocks and their hybrids that can be converted into (exchanged for) common stock or other securities, such as warrants or options, which provide an opportunity for equity participation. Once a convertible security converts to common stock, the Fund would be an equity owner of the particular company as a common stockholder. The Fund may…
From the fund's prospectus (filed Mar 5, 2026).
WMNAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| WMNAX | +7.6% | +4.3% | — |
| Alternatives median | +7.4% | +4.2% | +3.8% |
Source: Fund prospectus, as of Dec 31, 2025
What WMNAX costs
On a $10,000 investment, WMNAX's 1.01% expense ratio costs about $101 a year. The prospectus estimates $1,705 in total costs over 10 years (assuming 5% annual returns). The median alternatives fund charges 1.54%.
WMNAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | First American Funds Inc | 6.48% |
| 2 | Welltower Op Llc | 2.55% |
| 3 | Mks Inc | 2.49% |
| 4 | Akamai Technologies Inc | 2.28% |
| 5 | Ligand Pharmaceuticals Inc | 2.20% |
| 6 | Bridgebio Pharma Inc | 2.20% |
| 7 | Snowflake Inc | 2.19% |
| 8 | On Semiconductor Corp | 2.19% |
| 9 | Datadog Inc | 2.01% |
| 10 | Microchip Technology Inc | 2.00% |
Source: SEC Form N-PORT, period ended Jul 31, 2026
The top 10 make up 26.6% of the fund. See all top 25 holdings and asset mix →